Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Basurto

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
American Journal of Clinical Oncology|October 1, 1988
A double-blind trial comparing antiemetic efficacy and toxicity of metoclopramide versus methylprednisolone versus domperidone in patients receiving doxorubicin chemotherapy alone or in combination with other antiblastic agentsC Basurto, F Roila, S Bracarda, et al.
American Journal of Clinical Oncology|June 1, 1989
Antiemetic activity of high-dose metoclopramide combined with methylprednisolone versus metoclopramide alone in dacarbazine-treated cancer patients. A randomized double-blind study of the Italian Oncology Group for Clinical ResearchC Basurto, F Roila, M Tonato, et al.
Oncology|January 1, 1990
A pilot study of metoclopramide, dexamethasone, diphenhydramine and lorazepam in prevention of nausea and vomiting in cisplatin-treated male patientsF Roila, C Basurto, S Bracarda, et al.
Tumori|June 30, 1989
Lonidamine in advanced colorectal cancer: a phase II study of the Italian Oncology Group for Clinical Research (GOIRC)R Passalacqua, G Bisagni, M Bertusi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
A pilot study of metoclopramide, dexamethasone, diphenhydramine and acupuncture in women treated with cisplatinL Aglietti, F Roila, M Tonato, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Assessment of nauseaA Del Favero, F Roila, C Basurto, et al.
American Journal of Clinical Oncology|November 5, 1997
Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamideM Colozza, A M Mosconi, S Gori, et al.
American Journal of Clinical Oncology|April 1, 1992
Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patientsF Roila, S Bracarda, C Basurto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
OndansetronF Roila, M Tonato, C Basurto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesisF Roila, C Basurto, S Bracarda, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
American Journal of Clinical Oncology|October 1, 1988
A double-blind trial comparing antiemetic efficacy and toxicity of metoclopramide versus methylprednisolone versus domperidone in patients receiving doxorubicin chemotherapy alone or in combination with other antiblastic agentsC Basurto, F Roila, S Bracarda, et al.
American Journal of Clinical Oncology|June 1, 1989
Antiemetic activity of high-dose metoclopramide combined with methylprednisolone versus metoclopramide alone in dacarbazine-treated cancer patients. A randomized double-blind study of the Italian Oncology Group for Clinical ResearchC Basurto, F Roila, M Tonato, et al.
Oncology|January 1, 1990
A pilot study of metoclopramide, dexamethasone, diphenhydramine and lorazepam in prevention of nausea and vomiting in cisplatin-treated male patientsF Roila, C Basurto, S Bracarda, et al.
Tumori|June 30, 1989
Lonidamine in advanced colorectal cancer: a phase II study of the Italian Oncology Group for Clinical Research (GOIRC)R Passalacqua, G Bisagni, M Bertusi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
A pilot study of metoclopramide, dexamethasone, diphenhydramine and acupuncture in women treated with cisplatinL Aglietti, F Roila, M Tonato, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Assessment of nauseaA Del Favero, F Roila, C Basurto, et al.
American Journal of Clinical Oncology|November 5, 1997
Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamideM Colozza, A M Mosconi, S Gori, et al.
American Journal of Clinical Oncology|April 1, 1992
Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patientsF Roila, S Bracarda, C Basurto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
OndansetronF Roila, M Tonato, C Basurto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesisF Roila, C Basurto, S Bracarda, et al.
Pageof 4